- 20 years of experience in the radiopharmaceutical field with over 150 publications
- Supervised training of over 50 undergraduate, graduate and post-doctoral trainees
- 191 presentations including the plenary lecture at the 2009 Society of Nuclear Medicine meeting and the Kaplan award lecture at Harvard University (2010)
- Brockhouse Canada Prize for Interdisciplinary Research in Science and Engineering (2015)
- Canada’s Top 40 Under 40 (2010)
- Founder and CEO of the Centre for Probe Development and Commercialization (CPDC): a National Centre of Excellence
John Valliant, PhD
Professor McMaster University, Department of Chemistry and Chemical Biology
CEO, Centre for Probe Development and Commercialization
John Valliant, PhD, is a professor in Chemistry and Chemical Biology at McMaster University and the founder of the Centre for Probe Development and Commercialization (CPDC). The CPDC is a not for profit centre of excellence that is focused on bridging the gap between academia and industry, enabling the development and commercialization of promising imaging probes and associated technologies. The Centre employs more than 80 research scientists, production technologists, quality assurance specialists and regulatory affairs experts focused on discovering, developing and distributing the next generation of molecular imaging probes. CPDC also plays an important role in Ontario’s health care system, manufacturing and delivering a reliable, daily supply of imaging probes to hospitals across the province.
John is internationally recognized for his work in radiopharmaceutical chemistry, where his current research focuses on developing new radiolabeling methods and compound discovery strategies to create clinically relevant molecular imaging probes and therapeutic radiopharmaceuticals. In recognition of his work and the emergence of the CPDC, John gave the plenary lecture at the 2009 Society of Nuclear Medicine meeting and was selected as one of Canada’s 2009 Top 40 Under 40. A distinction that recognizes his exceptional work at CPDC and McMaster University to advance molecular probe technology, improve patient care and spur on economic growth. The award also acknowledges his commitment to education and training at McMaster and within the imaging industry. Dr. Valliant’s contribution to training highly qualified professionals within his research program is significant with several graduates taking research roles in both academic and industry settings in Canada and abroad.
Dr. Valliant has published more than 150 papers in refereed journals and conference proceedings, and has been invited to speak at scientific conferences and leading research centres the world over. He currently has 14 patents or patent applications under review.
Dr. Valliant completed his PhD at McMaster University, followed by a post-doctoral fellowship under the joint supervision of professors Alun G. Jones (Harvard) and Alan Davison (MIT). Returning to McMaster in 1999. He became an assistant professor and was promoted to associate professor in 2005.